Here we have applied an in-depth quantitative proteomic approach [16]–[18] to the analysis of plasma protein changes related to tumor development in a K-ras/Pten ovarian cancer mouse model to determine their involvement in pathways and networks and their correspondence to proteins expressed or released from human ovarian cancer cells. This evidence concerns the gene KRAS and neoplasm.